DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them
Click the patents below for more details, or visit DrugPatentWatch.com for more options.
|RELPAX (eletriptan hydrobromide)|
|Expiration Date:||Aug 29, 2017|
DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.
For more information try a trial
This post was originally published on this site